The leukapheresis market size was valued at $245.65 million in 2021, and is estimated to reach $561.6 million by 2031, growing at a CAGR of 8.6% from 2022 to 2031.
Leukapheresis is a medical procedure that involves the removal of white blood cells (leukocytes) from the blood. This procedure is often used to reduce the number of white blood cells in the blood prior to a bone marrow transplant, or in cases where the patient has a high white blood cell count due to certain medical conditions such as leukemia.
The global leukapheresis market is expected to grow in the coming years due to factors such as increasing incidence of cancer and blood disorders, growth in the number of bone marrow transplant procedures, and the development of new leukapheresis devices.
However, the market faces some challenges such as high costs associated with the procedure and lack of trained personnel. Despite these challenges, the demand for leukapheresis is expected to continue to grow as the number of bone marrow transplants and cancer treatments increase.
The leukapheresis market includes a wide range of products and services, including leukapheresis devices, disposable kits and accessories, and leukapheresis services. Major players in the market include Fresenius Medical Care, Terumo BCT, Asahi Kasei Medical, Haemonetics Corporation, and Meditech.
Download Free Sample Report (274 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/9449
The COVID-19 had a positive impact on the growth of the global leukapheresis market, as the vaccines which were undergoing clinical testing included research on white blood cells. This research played a crucial role in the creation of new vaccinations.
Moreover, research was carried out to determine how the COVID-19 affects white blood cells. For instance, to comprehend how SARS-CoV-2 affects lymphocytes, the NIH (National Institute of Health) performed clinical trials that called for leukapheresis.
Furthermore, the regularization of the supply chain of medications by key players and the rise in the number of patient visits for investigation and treatment fuelled the growth of the leukapheresis market in the post-pandemic period.
The report offers a detailed segmentation of the global leukapheresis market based on product, method, application, end user, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.
Based on product, the disposables segment held the largest share in 2021, accounting for more than two-thirds of the global leukapheresis market, and would rule the roost through 2031. The same segment is estimated to witness the fastest CAGR of 9.0% during the forecast period. The report also discusses the devices segments.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/9449
Based on the method, the centrifugation segment held the largest share in 2021, accounting for more than half of the global leukapheresis market, and would rule the roost through 2031. However, the membrane separation segment is estimated to witness the fastest CAGR of 9.3% during the forecast period. The report also discusses the selective adsorption segments.
In terms of application, the therapeutic applications segment captured the largest market share of around three-fifths in 2021 and is expected to lead the trail during the forecast period. However, the research applications segment is likely to achieve the fastest CAGR of 9.1% through 2031.
Based on end user, the blood centers segment held the largest share in 2021, contributing to more than two-fifths of the global leukapheresis market, and is likely to maintain its leadership status during the forecast period. However, the others segment is expected to manifest the highest CAGR of 9.3% from 2022 to 2031. The report also discusses the hospitals segment.
Based on region, the market in North America was the largest in 2021, accounting for more than two-fifths of the global leukapheresis market, and is likely to maintain its leadership status during the forecast period. However, the leukapheresis market in the Asia-Pacific is expected to manifest the highest CAGR of 10.1% from 2022 to 2031. The other regions analyzed in the study include Europe and LAMEA.
Leading players of the global leukapheresis market analyzed in the research include Adacyte Therapeutics, AllCells, LLC, Asahi Kasei Corporation, Charles River Laboratories International, Inc., Cerus Corporation, Fresenius Kabi, Haemonetics Corporation, SB-KAWASUMI LABORATORIES, INC., and Terumo BCT, Inc.
The report analyzes these key players of the global leukapheresis market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Other Trending Reports:
Hospital Information System Market>> https://www.alliedmarketresearch.com/hospital-information-system-market
Healthcare Fraud Detection Market>> https://www.alliedmarketresearch.com/medical-fraud-detection-management-market
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060